Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.
Genome Med. 2021 Jul 16;13(1):116. doi: 10.1186/s13073-021-00926-7.
Genome Med. 2021.
PMID: 34271981
Free PMC article.
A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
Möhrmann L, Zowada MK, Strakerjahn H, Siegl C, Kopp-Schneider A, Krunic D, Strunk D, Schneider M, Kriegsmann M, Kriegsmann K, Herbst F, Ball CR, Glimm H, Dieter SM.
Möhrmann L, et al. Among authors: zowada mk.
Int J Cancer. 2020 Jul 15;147(2):519-531. doi: 10.1002/ijc.32933. Epub 2020 Mar 4.
Int J Cancer. 2020.
PMID: 32077087
Item in Clipboard
Functional States in Tumor-Initiating Cell Differentiation in Human Colorectal Cancer.
Zowada MK, Tirier SM, Dieter SM, Krieger TG, Oberlack A, Chua RL, Huerta M, Ten FW, Laaber K, Park J, Jechow K, Müller T, Kalxdorf M, Kriegsmann M, Kriegsmann K, Herbst F, Krijgsveld J, Schneider M, Eils R, Glimm H, Conrad C, Ball CR.
Zowada MK, et al.
Cancers (Basel). 2021 Mar 4;13(5):1097. doi: 10.3390/cancers13051097.
Cancers (Basel). 2021.
PMID: 33806447
Free PMC article.
Item in Clipboard
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer.
Dieter SM, Siegl C, Codó PL, Huerta M, Ostermann-Parucha AL, Schulz E, Zowada MK, Martin S, Laaber K, Nowrouzi A, Blatter M, Kreth S, Westermann F, Benner A, Uhrig U, Putzker K, Lewis J, Haegebarth A, Mumberg D, Holton SJ, Weiske J, Toepper LM, Scheib U, Siemeister G, Ball CR, Kuster B, Stoehr G, Hahne H, Johannes S, Lange M, Herbst F, Glimm H.
Dieter SM, et al. Among authors: zowada mk.
Cell Rep. 2021 Jul 20;36(3):109394. doi: 10.1016/j.celrep.2021.109394.
Cell Rep. 2021.
PMID: 34289372
Free article.
Item in Clipboard
Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors.
Dieter SM, Lovecchio D, Pataskar A, Zowada MK, Körner PR, Khalizieva A, van Tellingen O, Jäger D, Glimm H, Agami R.
Dieter SM, et al. Among authors: zowada mk.
Oncogene. 2022 Aug;41(32):3953-3968. doi: 10.1038/s41388-022-02400-z. Epub 2022 Jul 7.
Oncogene. 2022.
PMID: 35798875
Free PMC article.
Item in Clipboard
Cite
Cite